Catalyst
Slingshot members are tracking this event:
Onconova Adjusts Pricing of Rights Offering
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ONTX |
|
|
Additional Information
Under the rights offering, Onconova has distributed 1.5 non-transferable subscription rights to purchase units per share of common stock or warrants. Each right entitles the holder to purchase one unit at the adjusted subscription price of $4.10 per unit, composed of one share of common stock and 0.75 of a warrant, with each whole warrant exercisable to purchase one share of common stock at an adjusted exercise price of $4.92 per share for five years from the date of issuance. Onconova has applied to list the warrants on NASDAQ under the symbol "ONTXW," although there is no assurance that a sufficient number of subscription rights will be exercised so that the warrants will meet the minimum listing criteria to be accepted for listing. After the one-year anniversary of issuance, the Company may redeem the Warrants for $0.001 per Warrant if the volume weighted average price of our common stock is above $12.30 per share for 10 consecutive trading days. The subscription rights are non-transferrable and may only be exercised during the subscription period.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 22, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rights Offering, Pricing, Non-transferrable